These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 35914624)

  • 1. The opioid system in depression.
    Jelen LA; Stone JM; Young AH; Mehta MA
    Neurosci Biobehav Rev; 2022 Sep; 140():104800. PubMed ID: 35914624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting opioid dysregulation in depression for the development of novel therapeutics.
    Browne CA; Lucki I
    Pharmacol Ther; 2019 Sep; 201():51-76. PubMed ID: 31051197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Targets to Treat Depression: Opioid-Based Therapeutics.
    Browne CA; Jacobson ML; Lucki I
    Harv Rev Psychiatry; 2020; 28(1):40-59. PubMed ID: 31913981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors.
    Puls K; Schmidhammer H; Wolber G; Spetea M
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.
    Martin M; Matifas A; Maldonado R; Kieffer BL
    Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
    Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
    Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta Opioid Receptor-Mediated Antidepressant-Like Effects of Diprenorphine in Mice.
    Olson KM; Hillhouse TM; Burgess GE; West JL; Hallahan JE; Dripps IJ; Ladetto AG; Rice KC; Jutkiewicz EM; Traynor JR
    J Pharmacol Exp Ther; 2023 Mar; 384(3):343-352. PubMed ID: 36456196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of opioidergic mechanisms related to the anti-migraine effect of vagus nerve stimulation.
    Hu B; Akerman S; Goadsby PJ
    Neuropharmacology; 2021 Sep; 195():108375. PubMed ID: 33444636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
    Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
    J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased Opioid Ligands.
    Faouzi A; Varga BR; Majumdar S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation.
    Ji RR; Zhang Q; Law PY; Low HH; Elde R; Hökfelt T
    J Neurosci; 1995 Dec; 15(12):8156-66. PubMed ID: 8613750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptors: distinct roles in mood disorders.
    Lutz PE; Kieffer BL
    Trends Neurosci; 2013 Mar; 36(3):195-206. PubMed ID: 23219016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
    Zaveri NT; Journigan VB; Polgar WE
    ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In major depression, increased kappa and mu opioid receptor levels are associated with immune activation.
    Al-Hakeim HK; Zeki Al-Fadhel S; Al-Dujaili AH; Maes M
    Acta Neuropsychiatr; 2020 Apr; 32(2):99-108. PubMed ID: 31753054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term alterations in mu, delta and kappa opioidergic receptors following middle cerebral artery occlusion in mice.
    Boutin H; Catherine A; Mackenzie ET; Jauzac P; Dauphin F
    Acta Neuropathol; 2007 Nov; 114(5):491-500. PubMed ID: 17676326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
    Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
    Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ.
    Donica CL; Awwad HO; Thakker DR; Standifer KM
    Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors.
    Homberg JR; Mul JD; de Wit E; Cuppen E
    Neuroscience; 2009 Sep; 163(1):308-15. PubMed ID: 19527777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
    Olianas MC; Concas D; Onali P
    Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors.
    Falcon E; Browne CA; Leon RM; Fleites VC; Sweeney R; Kirby LG; Lucki I
    Neuropsychopharmacology; 2016 Aug; 41(9):2344-51. PubMed ID: 26979295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.